s6y

PRF Technologies Ltd.

Ticker
PRFX
CIK
1801834
Industry
Pharmaceutical Preparations
Formerly
PAINREFORM LTD.

Ownership 24

  1. 3 Initial statement of beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. SC 13G/A Major Shareholders
  9. SC 13G/A Major Shareholders
  10. SC 13D/A Major Shareholders

All 24 ownership filings

Prospectus 25

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 25 prospectus filings

Other 217

  1. SCHEDULE 13D/A
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. SCHEDULE 13D/A
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. SCHEDULE 13D
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 217 other filings